Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
Incyte Corporation
Trishula Therapeutics, Inc.
Institut Bergonié
Intensity Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Eisai Inc.
City of Hope Medical Center
Novartis
Incyte Corporation
Institut Bergonié
Amgen
Incyte Corporation
Amgen
Altor BioScience